Kyongbo Pharmaceutical Statistics

Total Valuation

KRX:214390 has a market cap or net worth of KRW 130.29 billion. The enterprise value is 224.80 billion.

Market Cap	130.29B
Enterprise Value	224.80B

Important Dates

The last earnings date was Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

KRX:214390 has 23.91 million shares outstanding. The number of shares has decreased by -0.33% in one year.

Current Share Class	23.91M
Shares Outstanding	23.91M
Shares Change (YoY)	-0.33%
Shares Change (QoQ)	+0.21%
Owned by Insiders (%)	17.13%
Owned by Institutions (%)	1.84%
Float	9.13M

Valuation Ratios

The trailing PE ratio is 56.81.

PE Ratio	56.81
Forward PE	n/a
PS Ratio	0.55
PB Ratio	0.90
P/TBV Ratio	0.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.07, with an EV/FCF ratio of -12.63.

EV / Earnings	97.96
EV / Sales	0.95
EV / EBITDA	12.07
EV / EBIT	36.51
EV / FCF	-12.63

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.68.

Current Ratio	1.08
Quick Ratio	0.41
Debt / Equity	0.68
Debt / EBITDA	4.93
Debt / FCF	-5.53
Interest Coverage	1.75

Financial Efficiency

Return on equity (ROE) is 1.59% and return on invested capital (ROIC) is 2.02%.

Return on Equity (ROE)	1.59%
Return on Assets (ROA)	1.68%
Return on Invested Capital (ROIC)	2.02%
Return on Capital Employed (ROCE)	5.05%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.85
Inventory Turnover	1.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.75% in the last 52 weeks. The beta is 1.22, so KRX:214390's price volatility has been higher than the market average.

Beta (5Y)	1.22
52-Week Price Change	-26.75%
50-Day Moving Average	5,402.40
200-Day Moving Average	6,687.45
Relative Strength Index (RSI)	51.61
Average Volume (20 Days)	16,631

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:214390 had revenue of KRW 236.54 billion and earned 2.29 billion in profits. Earnings per share was 95.94.

Revenue	236.54B
Gross Profit	83.39B
Operating Income	7.52B
Pretax Income	1.96B
Net Income	2.29B
EBITDA	19.98B
EBIT	7.52B
Earnings Per Share (EPS)	95.94

Full Income Statement

Balance Sheet

The company has 3.91 billion in cash and 98.42 billion in debt, giving a net cash position of -94.51 billion or -3,953.10 per share.

Cash & Cash Equivalents	3.91B
Total Debt	98.42B
Net Cash	-94.51B
Net Cash Per Share	-3,953.10
Equity (Book Value)	144.09B
Book Value Per Share	6,014.07
Working Capital	11.60B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.42 billion and capital expenditures -16.37 billion, giving a free cash flow of -17.79 billion.

Operating Cash Flow	-1.42B
Capital Expenditures	-16.37B
Free Cash Flow	-17.79B
FCF Per Share	-744.25

Full Cash Flow Statement

Margins

Gross margin is 35.25%, with operating and profit margins of 3.18% and 0.97%.

Gross Margin	35.25%
Operating Margin	3.18%
Pretax Margin	0.83%
Profit Margin	0.97%
EBITDA Margin	8.45%
EBIT Margin	3.18%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.92%.

Dividend Per Share	50.00
Dividend Yield	0.92%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	52.09%
Buyback Yield	0.33%
Shareholder Yield	1.25%
Earnings Yield	1.76%
FCF Yield	-13.66%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KRX:214390 has an Altman Z-Score of 2.07. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.07
Piotroski F-Score	n/a